Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1959 Apr;90(4):284–287.

Dermatomyositis Treated with Sodium Ethylenediamine-tetra-acetate

R C Pollock
PMCID: PMC1577628  PMID: 13638842

Full text

PDF
284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELLIN J., LASZLO D. Metabolism and removal of Ca45 in man. Science. 1953 Mar 27;117(3039):331–334. doi: 10.1126/science.117.3039.331. [DOI] [PubMed] [Google Scholar]
  2. BRUNSTING L. A., CHRISTIANSON H. B., PERRY H. O. Dermatomyositis; unusual features, complications, and treatment. AMA Arch Derm. 1956 Dec;74(6):581–589. [PubMed] [Google Scholar]
  3. CLARKE C. N., CLARKE N. E., MOSHER R. E. Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid. Am J Med Sci. 1956 Dec;232(6):654–666. doi: 10.1097/00000441-195612000-00006. [DOI] [PubMed] [Google Scholar]
  4. CLARKE N. E., CLARKE C. N., MOSHER R. E. The in vivo dissolution of metastatic calcium; an approach to atherosclerosis. Am J Med Sci. 1955 Feb;229(2):142–149. doi: 10.1097/00000441-195502000-00004. [DOI] [PubMed] [Google Scholar]
  5. CURTIS A. C., BLAYLOCK H. C., HARRELL E. R., Jr Malignant lesions associated with dermatomyositis. J Am Med Assoc. 1952 Nov 1;150(9):844–846. doi: 10.1001/jama.1952.03680090008004. [DOI] [PubMed] [Google Scholar]
  6. DOMZALSKI C. A., MORGAN V. C. Dermatomyositis: diagnostic features and therapeutic pitfalls. Am J Med. 1955 Sep;19(3):370–382. doi: 10.1016/0002-9343(55)90126-1. [DOI] [PubMed] [Google Scholar]
  7. DUDLEY H. R., RITCHIE A. C., SCHILLING A., BAKER W. H. Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia; report of two cases with autopsy findings. N Engl J Med. 1955 Mar 3;252(9):331–337. doi: 10.1056/NEJM195503032520901. [DOI] [PubMed] [Google Scholar]
  8. HOLLAND J. F., DANIELSON E., SAHAGIAN-EDWARDS A. Use of ethylene diamine tetra acetic acid in hypercalcemic patients. Proc Soc Exp Biol Med. 1953 Nov;84(2):359–364. doi: 10.3181/00379727-84-20645. [DOI] [PubMed] [Google Scholar]
  9. KLEIN R., HARRIS S. B. Treatment of scleroderma, sclerodactylia and calcinosis by chelation (EDTA). Am J Med. 1955 Nov;19(5):798–807. doi: 10.1016/s0002-9343(55)80025-3. [DOI] [PubMed] [Google Scholar]
  10. POPOVICI A., GESCHICKTER C. F., REINOVSKY A., RUBIN M. Experimental control of serum calcium levels in vivo. Proc Soc Exp Biol Med. 1950 Jun;74(2):415–417. doi: 10.3181/00379727-74-17924. [DOI] [PubMed] [Google Scholar]
  11. ROBERTS H. M., BRUNSTING L. A. Dermatomyositis in childhood; a summary of 40 cases. Postgrad Med. 1954 Nov;16(5):396–404. doi: 10.1080/00325481.1954.11711712. [DOI] [PubMed] [Google Scholar]
  12. SPENCER H., GREENBERG J., BERGER E., PERRONE M., LASZLO D. Studies on the effect of ethylenediaminetetraacetic acid in hypercalcemia. J Lab Clin Med. 1956 Jan;47(1):29–41. [PubMed] [Google Scholar]
  13. SPENCER H., VANKINSCOTT V., LEWIN I., LASZLO D. Removal of calcium in man by ethylenediamine tetra-acetic acid. A metabolic study. J Clin Invest. 1952 Dec;31(12):1023–1027. doi: 10.1172/JCI102694. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES